Efficacy of medical-grade honey as an autolytic debridement agent

Clinicians have knowledge, skill, and experience of the wound debridement methods and products available to them. To enable them to make informed decisions on which wound debridement processor product is the most appropriate, it is essential that clinicians have access to clinical and cost-effectiveness data. However, the lack of robust evidence to support wound care products is well documented (Gottrup et al, 2010). The case studies presented here were undertaken by the All Wales Tissue Viability Nurse Forum (AWTVNF) and enabled the Forum to gain direct experience using honey as an autolytic debriding agent, evaluate its effectiveness, and achieve positive clinical outcomes for patients involved.